自己免疫疾患診断の市場規模、シェア、動向分析レポート：タイプ別、製品タイプ別、検査タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

自己免疫疾患診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の自己免疫疾患診断市場規模は、2025年から2030年にかけてCAGR 6.18%で拡大し、2030年には82億米ドルに達すると推定されています。

政府機関や関連団体は、このような高額な医療費を抑制すると同時に、患者に改善された診断・治療ソリューションを提供しようと努力しています。その結果、NIHによる自己免疫疾患関連の研究開発プログラムへの資金提供が増加しています。

さらに、これらの疾患の発生を抑制し、実行可能な診断・治療オプションを開発することを目的とした、政府による好意的なイニシアチブの存在は、予測期間中の市場成長を促進すると予想されます。

自己免疫診断処置の増加により、より迅速で効果的な結果をもたらす機器や設備に対するニーズが高まっています。増え続ける処置量に対応するため、診断ラボは急速に自動化に向かっています。ラボの自動化は、迅速なターンアラウンドタイムによる作業負荷の軽減を助け、標準化された再現性のある結果の生成を支援します。

自己免疫疾患診断市場レポートハイライト

• 局所自己免疫疾患診断分野が市場を独占し、2024年の売上高シェアは64.25%。
• 消耗品＆アッセイ部門は2024年に70.43％の最大収益シェアを占めました。すべての臨床検査診断テストは、テストキット、試薬、抗体を利用します。
• 検査タイプ別では、抗核抗体検査が2024年に42.62%の収益シェアで市場を独占しました。このセグメントの成長は、手頃な価格、高感度、豊富な入手可能性によるものです。
• 病院セグメントは2024年に53.32％の収益シェアで市場を独占しました。この高いシェアは、様々な疾患に対する病院での自己免疫疾患診断の採用が増加していることに起因しています。
• 北米の自己免疫疾患診断市場は世界市場を独占し、2024年の売上高シェアは42.70%でした。アジア太平洋の自己免疫疾患診断市場は、2024年から2030年にかけて最も速いCAGRを記録すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 タイプ別ビジネス分析

• 自己免疫疾患診断市場：タイプ別変動分析
• 全身性自己免疫疾患の診断
  • 全身性自己免疫疾患診断市場、2018年～2030年
  • 関節リウマチの診断
  • 強直性脊椎炎の診断
  • 全身性エリテマトーデス（SLE）の診断
  • その他の全身性自己免疫疾患の診断
• 局所疾患診断
  • 局所的疾患診断市場、2018年～2030年
  • 多発性硬化症の診断
  • 1型糖尿病の診断
  • 橋本病性甲状腺炎の診断
  • 特発性血小板減少性紫斑病（ITP）の診断
  • その他の局所的自己免疫疾患の診断

第5章 製品タイプ別ビジネス分析

• 自己免疫疾患診断市場：製品タイプ別変動分析
• 機器
• 消耗品とアッセイ

第6章 検査タイプ別ビジネス分析

• 自己免疫疾患診断市場：検査タイプ別変動分析
• 抗核抗体検査
• 自己抗体検査
• C反応性タンパク質（CRP）
• 全血球数（CBC）
• 尿検査
• その他

第7章 最終用途別ビジネス分析

• 自己免疫疾患診断市場：最終用途別変動分析
• 病院
• 診断センター
• その他

第8章 地域別ビジネス分析

• 自己免疫疾患診断市場シェア：地域別、2024年および2030年
• 北米
  • SWOT分析
  • 北米の自己免疫疾患診断市場、2018年～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • SWOT分析
  • 欧州自己免疫疾患診断市場、2018年～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋
  • SWOT分析
  • アジア太平洋地域の自己免疫疾患診断市場、2018年～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • SWOT分析
  • ラテンアメリカの自己免疫疾患診断市場、2018年～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • SWOT分析
  • 中東・アフリカの自己免疫疾患診断市場、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市場シェア分析、2024年
• 企業プロファイル/上場企業
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare Private Limited
  • Abbott
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Quest Diagnostics
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Nova Diagnostics Pte Ltd.
  • BIOMERIEUX
  • Hemagen Diagnostics, Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Autoimmune Disease Diagnostics Market, By Region, 2018 - 2030 (USD Million)
• Table 4 Global Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
• Table 5 Global Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 6 Global Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 7 Global Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 8 North America Autoimmune Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
• Table 10 North America Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 11 North America Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 12 North America Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 14 U.S. Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 15 U.S. Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 16 U.S. Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
• Table 18 Canada Autoimmune Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
• Table 19 Canada Autoimmune Disease Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Table 20 Canada Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 22 Mexico Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 23 Mexico Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 24 Mexico Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 26 Europe Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 27 Europe Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 28 Europe Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 29 Europe Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 30 UK Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 31 UK Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 32 UK Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 33 UK Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 34 Germany Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 35 Germany Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 36 Germany Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 37 Germany Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 38 France Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 39 France Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 40 France Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 41 France Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 43 Italy Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 44 Italy Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 45 Italy Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 47 Spain Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 48 Spain Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 49 Spain Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 50 Sweden Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 51 Sweden Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 52 Sweden Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 53 Sweden Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 54 Norway Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 55 Norway Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 56 Norway Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 57 Norway Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 58 Denmark Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 59 Denmark Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 60 Denmark Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 61 Denmark Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 67 Japan Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 68 Japan Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 69 Japan Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 70 Japan Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 71 China Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 72 China Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 73 China Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 74 China Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 75 India Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 76 India Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 77 India Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 78 India Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 79 Australia Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 80 Australia Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 81 Australia Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 82 Australia Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 83 Thailand Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 84 Thailand Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 85 Thailand Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 86 Thailand Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 87 South Korea Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 88 South Korea Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 89 South Korea Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 90 South Korea Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 91 Latin America Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 92 Latin America Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 93 Latin America Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 94 Latin America Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 95 Latin America Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 96 Brazil Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 97 Brazil Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 98 Brazil Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 99 Brazil Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 100 Argentina Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 101 Argentina Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 102 Argentina Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 103 Argentina Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 104 MEA Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Table 105 MEA Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 106 MEA Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 107 MEA Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 108 MEA Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 109 South Africa Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 110 South Africa Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 111 South Africa Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 112 South Africa Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 117 UAE Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
• Table 118 UAE Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 119 UAE Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 120 UAE Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 121 Kuwait Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD)
• Table 122 Kuwait Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 123 Kuwait Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
• Table 124 Kuwait Autoimmune Disease Diagnostics Market, By End Use, 32018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Autoimmune Disease Diagnostics Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 Penetration & Growth Prospect Mapping
• Fig. 12 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 13 Porter's Five Forces Analysis
• Fig. 14 Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
• Fig. 15 Autoimmune Disease Diagnostics Market: Type Movement Analysis & Market Share 2024 & 2030
• Fig. 16 Implementation Of the Amp Ra/SLE Program, By Research Phase
• Fig. 17 Global Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 18 Global Rheumatoid Arthritis Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 19 Global Ankylosing Spondylitis Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 20 Global Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 21 Global Other Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 22 Global Localized Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 23 Global Multiple Sclerosis Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 24 Global Type 1 Diabetes Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 25 Global Hashimoto's Thyroiditis Diagnostics Market, 2013 - 2025 (USD Millio2018 - 2030 (USD Million)
• Fig. 26 Global Idiopathic Thrombocytopenic Purpura Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 27 Global Other Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 28 Autoimmune Disease Diagnostics Market: Product Outlook and Key Takeaways
• Fig. 29 Autoimmune Disease Diagnostics Market: Product Movement Analysis & Market Share
• Fig. 30 Global Instruments Market, 2018 - 2030 (USD Million)
• Fig. 31 Global Consumables and Assays Tests Market, 2018 - 2030 (USD Million)
• Fig. 32 Autoimmune Disease Diagnostics Market: Test Type Outlook and Key Takeaways
• Fig. 33 Autoimmune Disease Diagnostics Market: Test Type Movement Analysis & Market Share
• Fig. 34 Global Antinuclear Antibody Tests Market, 2018 - 2030 (USD Million)
• Fig. 35 Global Autoantibody Tests Market, 2018 - 2030 (USD Million)
• Fig. 36 Global C-Reactive Protein (CRP) Market, 2018 - 2030 (USD Million)
• Fig. 37 Global Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
• Fig. 38 Global Urinalysis Market, 2018 - 2030 (USD Million)
• Fig. 39 Global Others Market, 2018 - 2030 (USD Million)
• Fig. 40 Autoimmune Disease Diagnostics Market: End Use Outlook and Key Takeaways
• Fig. 41 Autoimmune Disease Diagnostics Market: End Use Movement Analysis & Market Share
• Fig. 42 Global Hospitals Market, 2018 - 2030 (USD Million)
• Fig. 43 Global Diagnostic Centres Market, 2018 - 2030 (USD Million)
• Fig. 44 Global Others Market, 2018 - 2030 (USD Million)
• Fig. 45 Regional Marketplace: Key Takeaways
• Fig. 46 Regional Outlook, 2024 & 2030
• Fig. 47 Regional Market Dashboard
• Fig. 48 Regional Market Place: Key Takeaways
• Fig. 49 North America, Swot Analysis
• Fig. 50 Europe, Swot Analysis
• Fig. 51 Asia Pacific, Swot Analysis
• Fig. 52 Latin America, Swot Analysis
• Fig. 53 MEA, Swot Analysis
• Fig. 54 North America
• Fig. 55 North America Autoimmune Disease Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 56 U.S. Key Country Dynamics
• Fig. 57 U.S. America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 58 Canada Key Country Dynamics
• Fig. 59 Canada America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 60 Mexico Key Country Dynamics
• Fig. 61 Mexico America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 62 Europe America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 63 UK Key Country Dynamics
• Fig. 64 UK America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 65 Germany Key Country Dynamics
• Fig. 66 Germany America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 67 France Key Country Dynamics
• Fig. 68 France America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 69 Italy Key Country Dynamics
• Fig. 70 Italy America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 71 Spain Key Country Dynamics
• Fig. 72 Spain America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 73 Sweden Key Country Dynamics
• Fig. 74 Sweden America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 75 Norway Key Country Dynamics
• Fig. 76 Norway America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 77 Denmark Key Country Dynamics
• Fig. 78 Denmark America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 79 Asia Pacific America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 80 Japan Key Country Dynamics
• Fig. 81 Japan America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 82 China Key Country Dynamics
• Fig. 83 China America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 84 India Key Country Dynamics
• Fig. 85 India America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 86 Australia Key Country Dynamics
• Fig. 87 Australia America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 88 Thailand Key Country Dynamics
• Fig. 89 Thailand America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 90 South Korea Key Country Dynamics
• Fig. 91 South Korea America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 92 Latin America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 93 Brazil Key Country Dynamics
• Fig. 94 Brazil America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 95 Argentina Key Country Dynamics
• Fig. 96 Argentina America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 97 Middle East and Africa America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 98 South Africa Key Country Dynamics
• Fig. 99 South Africa America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 100 Saudi Arabia Key Country Dynamics
• Fig. 101 Saudi Arabia America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 102 UAE Key Country Dynamics
• Fig. 103 UAE America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 104 Kuwait Key Country Dynamics
• Fig. 105 Kuwait America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 106 Strategy Mapping

Autoimmune Disease Diagnostics Market Growth & Trends:

The global autoimmune disease diagnostics market size is estimated to reach USD 8.20 billion by 2030, expanding at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.

Moreover, the presence of favorable government initiatives aimed at curbing the incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.

Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.

Autoimmune Disease Diagnostics Market Report Highlights:

• The localized autoimmune disease diagnostics segment dominated the market and accounted for a revenue share of 64.25% in 2024.
• The consumables & assays segment accounted for the largest revenue share of 70.43% in 2024. Every laboratory diagnostic test utilizes test kits, reagents, and antibodies.
• In terms of test type, the antinuclear antibody tests dominated the market with a revenue share of 42.62% in 2024. The growth of this segment is attributed to affordability, high sensitivity, and extensive availability.
• The hospital segment dominated the market in 2024 with a revenue share of 53.32%. The high share is attributed to the increased adoption of autoimmune disease diagnostic practices in hospitals for various diseases.
• The North America autoimmune disease diagnostics market dominated the global industry and accounted for a revenue share of 42.70% in 2024. The Asia Pacific autoimmune disease diagnostics market is anticipated to witness a fastest CAGR from 2024 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Type segment
    • 1.1.1.2. Product segment
    • 1.1.1.3. Test Type segment
    • 1.1.1.4. End use segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
  • 1.4.3. Objective - 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Type and Test Type Snapshot
• 2.3. Product and End Use Snapshot
• 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Presence of research funding programs
    • 3.2.1.2. Presence of favorable government initiatives
    • 3.2.1.3. Growing patient awareness levels
    • 3.2.1.4. Technological innovation in the form of lab automation
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Slow diagnostic result turnaround times and lack of skilled healthcare practitioners
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

• 4.1. Autoimmune Disease Diagnostics Market: Type Movement Analysis
• 4.2. Systemic Autoimmune Disease Diagnostics
  • 4.2.1. Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.2.2. Rheumatoid Arthritis Diagnostics
    • 4.2.2.1. Rheumatoid Arthritis Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.2.3. Ankylosing Spondylitis Diagnostics
    • 4.2.3.1. Ankylosing Spondylitis Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.2.4. Systemic Lupus Erythematosus (SLE) Diagnostics
    • 4.2.4.1. Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.2.5. Other Systemic Autoimmune Disease Diagnostics
    • 4.2.5.1. Other Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• 4.3. Localized Disease Diagnostics
  • 4.3.1. Localized Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3.2. Multiple sclerosis diagnostics
    • 4.3.2.1. Multiple Sclerosis Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3.3. Type 1 Diabetes Diagnostics
    • 4.3.3.1. Type 1 Diabetes Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3.4. Hashimoto's Thyroiditis Diagnostics
    • 4.3.4.1. Hashimoto's Thyroiditis Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3.5. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
    • 4.3.5.1. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3.6. Other Localized Autoimmune Disease Diagnostics
    • 4.3.6.1. Other Localized Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

• 5.1. Autoimmune Disease Diagnostics Market: Product Movement Analysis
• 5.2. Instruments
  • 5.2.1. Instruments Market, 2018 - 2030 (USD Million)
• 5.3. Consumables and Assays
  • 5.3.1. Consumables and Assays Market, 2018 - 2030 (USD Million)

Chapter 6. Test Type Business Analysis

• 6.1. Autoimmune Disease Diagnostics Market: Test Type Movement Analysis
• 6.2. Antinuclear Antibody Tests
  • 6.2.1. Antinuclear Antibody Tests Market, 2018 - 2030 (USD Million)
• 6.3. Autoantibody Tests
  • 6.3.1. Autoantibody Tests Market, 2018 - 2030 (USD Million)
• 6.4. C-reactive Protein (CRP)
  • 6.4.1. C-Reactive Protein (CRP) Market, 2018 - 2030 (USD Million)
• 6.5. Complete Blood Count (CBC)
  • 6.5.1. Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
• 6.6. Urinalysis
  • 6.6.1. Urinalysis Market, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. Autoimmune Disease Diagnostics Market: End Use Movement Analysis
• 7.2. Hospitals
  • 7.2.1. Hospitals Market, 2018 - 2030 (USD Million)
• 7.3. Diagnostic Centers
  • 7.3.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
• 7.4. Others
  • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Autoimmune Disease Diagnostics Market Share By Region, 2024 & 2030
• 8.2. North America
  • 8.2.1. SWOT Analysis
  • 8.2.2. North America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.2.3. U.S.
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Target Disease Prevalence
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Regulatory Framework
    • 8.2.3.5. U.S. Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.2.4. Canada
    • 8.2.4.1. Key Country Dynamics
    • 8.2.4.2. Target Disease Prevalence
    • 8.2.4.3. Competitive Scenario
    • 8.2.4.4. Regulatory Framework
    • 8.2.4.5. Canada Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.2.5. Mexico
    • 8.2.5.1. Key Country Dynamics
    • 8.2.5.2. Target Disease Prevalence
    • 8.2.5.3. Competitive Scenario
    • 8.2.5.4. Regulatory Framework
    • 8.2.5.5. Mexico Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. SWOT Analysis
  • 8.3.2. Europe Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.3. UK
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Target Disease Prevalence
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Regulatory Framework
    • 8.3.3.5. UK Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.4. Germany
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Target Disease Prevalence
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. Regulatory Framework
    • 8.3.4.5. Germany Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.5. France
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Target Disease Prevalence
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Regulatory Framework
    • 8.3.5.5. France Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.6. Italy
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Target Disease Prevalence
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Regulatory Framework
    • 8.3.6.5. Italy Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.7. Spain
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Target Disease Prevalence
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Regulatory Framework
    • 8.3.7.5. Spain Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.8. UK
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Target Disease Prevalence
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Regulatory Framework
    • 8.3.8.5. UK Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.9. Sweden
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Target Disease Prevalence
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Regulatory Framework
    • 8.3.9.5. Sweden Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.10. Norway
    • 8.3.10.1. Key Country Dynamics
    • 8.3.10.2. Target Disease Prevalence
    • 8.3.10.3. Competitive Scenario
    • 8.3.10.4. Regulatory Framework
    • 8.3.10.5. Norway Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3.11. Denmark
    • 8.3.11.1. Key Country Dynamics
    • 8.3.11.2. Target Disease Prevalence
    • 8.3.11.3. Competitive Scenario
    • 8.3.11.4. Regulatory Framework
    • 8.3.11.5. Denmark Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. SWOT Analysis
  • 8.4.2. Asia Pacific Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4.3. Japan
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Target Disease Prevalence
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Regulatory Framework
    • 8.4.3.5. Japan Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4.4. China
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Target Disease Prevalence
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. Regulatory Framework
    • 8.4.4.5. China Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4.5. India
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Target Disease Prevalence
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Regulatory Framework
    • 8.4.5.5. India Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4.6. Australia
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Target Disease Prevalence
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Regulatory Framework
    • 8.4.6.5. Australia Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4.7. Thailand
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Target Disease Prevalence
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. Regulatory Framework
    • 8.4.7.5. Thailand Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4.8. South Korea
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Target Disease Prevalence
    • 8.4.8.3. Competitive Scenario
    • 8.4.8.4. Regulatory Framework
    • 8.4.8.5. South Korea Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. SWOT Analysis
  • 8.5.2. Latin America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5.3. Brazil
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Target Disease Prevalence
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Regulatory Framework
    • 8.5.3.5. Brazil Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5.4. Argentina
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Target Disease Prevalence
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Regulatory Framework
    • 8.5.4.5. Argentina Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
• 8.6. MEA
  • 8.6.1. SWOT Analysis
  • 8.6.2. MEA Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6.3. South Africa
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Target Disease Prevalence
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Regulatory Framework
    • 8.6.3.5. South Africa Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6.4. Saudi Arabia
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Target Disease Prevalence
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Regulatory Framework
    • 8.6.4.5. Saudi Arabia Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6.5. UAE
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Target Disease Prevalence
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Regulatory Framework
    • 8.6.5.5. UAE Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6.6. Kuwait
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Target Disease Prevalence
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Regulatory Framework
    • 8.6.6.5. Kuwait Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Share Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. F. Hoffmann-La Roche Ltd
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Siemens Healthcare Private Limited
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Abbott
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Beckman Coulter, Inc.
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Danaher Corporation
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Quest Diagnostics
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. EUROIMMUN Medizinische Labordiagnostika AG
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Nova Diagnostics Pte Ltd.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. BIOMERIEUX
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Hemagen Diagnostics, Inc.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives